Recent

% | $
Quotes you view appear here for quick access.

Aethlon Medical, Inc. Message Board

  • eitzenschild eitzenschild Feb 22, 2014 4:31 PM Flag

    Need a catalyst or two

    If the exosome activity is not "near term" as Zacks suggests then we have only a few options in the spring:

    Hep C moves forward and partners need to be prominent
    Someone OTHER THAN Aethlon needs a good deal, a breakthrough or big publicity and we ride their wave. I don't see any other options.

    Some of us have asked the question before---is the only real driver cancer now? Wasn't there chatter about concussions and an announcement from the NFL during the Super Bowl? Sepsis? Sure there's a market for Hep C outside of the improved drugs coming out with Gilead, etc. but isn't the market much smaller now?

    The dilution of shares has to subside. 20% of the exosome subsidiary is now owned by someone else. I'd be interested in an alternative take on this view; shoot, I'd take some serious discussion about anything at this point.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEMD
6.01-0.13(-2.12%)Jun 24 4:00 PMEDT